| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/07/1993 | CA1321963C Modification of the dna sequence between the shine-dalgarno sequence and the start codon of the trp operon to increase protein expression |
| 09/07/1993 | CA1321962C Dental caries preventive preparations and method for preparing said preparations |
| 09/05/1993 | WO1993017697A1 Method of delivering therapeutic substances to the brain |
| 09/05/1993 | CA2102519A1 Method of delivering therapeutic substances to the brain |
| 09/05/1993 | CA2091052A1 Procedure for bovine nuclear transfer |
| 09/05/1993 | CA2090834A1 Analysis of host cell shut-offs |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/02/1993 | WO1993017127A1 Boomerand dna amplification |
| 09/02/1993 | WO1993017126A1 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
| 09/02/1993 | WO1993017125A1 Oligonucleotide modulation of cell growth |
| 09/02/1993 | WO1993017124A1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 09/02/1993 | WO1993017123A1 Mutagenicity testing using reporter genes with modified methylation frequencies |
| 09/02/1993 | WO1993017122A1 Protein with novel pharmacological characteristic |
| 09/02/1993 | WO1993017119A2 A 90k tumor-associated antigen, ir-95 |
| 09/02/1993 | WO1993017118A2 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | WO1993017117A1 Heterologous gene expression in lactococcus, and the expression products therefrom |
| 09/02/1993 | WO1993017116A1 Agrobacterium strains capable of site-specific recombination |
| 09/02/1993 | WO1993017114A1 Bile acid sulfate sulfatase gene, plasmid containing said gene, and productino of bile acid sulfate sulfatase |
| 09/02/1993 | WO1993017113A1 RECOMBINANT β-LACTAMASE USABLE AS CARRIER MOLECULE FOR THE PREPARATION OF IMMUNOGENIC COMPOSITIONS |
| 09/02/1993 | WO1993017112A1 Biosynthesis of methionine using a reduced source of sulfur |
| 09/02/1993 | WO1993017111A1 Hepatitis c virus peptides |
| 09/02/1993 | WO1993017110A2 A recombinant hepatitis c virus polypeptide |
| 09/02/1993 | WO1993017109A1 Ibv spike protein (2) |
| 09/02/1993 | WO1993017108A2 Analogous peptides of the internal image of a viral protein |
| 09/02/1993 | WO1993017107A1 Improvements in or relating to malaria vaccine |
| 09/02/1993 | WO1993017106A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/02/1993 | WO1993017105A1 Altered antibodies, products and processes relating thereto |
| 09/02/1993 | WO1993017104A1 Dna sequence of myotonic distrophy gene and uses thereof |
| 09/02/1993 | WO1993017103A1 Tightly regulated expression system for eucaryotic cells |
| 09/02/1993 | WO1993017102A1 MODULATIONS OF CELLULAR FUNCTIONS WITH HnRNP PROTEINS |
| 09/02/1993 | WO1993017101A1 Endo-1,4-beta-d-glucanase |
| 09/02/1993 | WO1993017098A1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| 09/02/1993 | WO1993017095A1 In vitro activation of cytotoxic t cells |
| 09/02/1993 | WO1993017093A2 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 09/02/1993 | WO1993017043A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
| 09/02/1993 | WO1993017031A2 Nucleic acids encoding dystrophin-associated proteins |
| 09/02/1993 | WO1993017030A1 Immunological detection of organophosphates |
| 09/02/1993 | WO1993016725A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 09/02/1993 | WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens |
| 09/02/1993 | WO1993016715A1 Fsf-1 and the early detection of fibrosis |
| 09/02/1993 | WO1993016709A1 Therapeutic domains of von willebrand factor |
| 09/02/1993 | WO1993013740A3 Antiparasitic oligonucleotides active against drug resistant malaria |
| 09/02/1993 | CA2131028A1 Hepatitis c virus peptides |
| 09/02/1993 | CA2130997A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | CA2130802A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | CA2130562A1 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
| 09/02/1993 | CA2130453A1 Heterologous gene expression in lactococcus, and the expression products threrefrom |
| 09/02/1993 | CA2130347A1 Biosynthesis of methionine using a reduced source of sulfur |
| 09/02/1993 | CA2130264A1 Oligonucleotide modulation of cell growth |
| 09/02/1993 | CA2130082A1 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 09/02/1993 | CA2129827A1 Analogous peptides of a viral protein internal image |
| 09/02/1993 | CA2125405A1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 09/02/1993 | CA2117608A1 Endo-1,4-beta-d-glucanase |
| 09/02/1993 | CA2117607A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | CA2117491A1 Car receptors and related molecules and methods |
| 09/02/1993 | CA2117468A1 Ibv spike protein (2) |
| 09/01/1993 | EP0558290A2 An improved differential screening protocol that allows the detection of marginally induced or repressed mRNAs |
| 09/01/1993 | EP0558257A1 Gaucher's disease: detection of a new mutation in intron 2 of the glucocerebrosidase gene |
| 09/01/1993 | EP0558241A2 A new cephalosporin C acylase |
| 09/01/1993 | EP0558024A2 Novel vector having promoter that is inducible by methanol and/or glycerol |
| 09/01/1993 | EP0557966A1 Prostaglandin E receptors, their DNA and production |
| 09/01/1993 | EP0557897A1 Antigen binding proteins and methods for their production |
| 09/01/1993 | EP0557663A1 Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin |
| 09/01/1993 | EP0557535A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 09/01/1993 | EP0557469A1 Plant medium-chain thioesterases |
| 09/01/1993 | EP0557459A1 Bifunctional selectable fusion genes. |
| 09/01/1993 | EP0557455A1 Recombinant feline coronavirus s proteins |
| 09/01/1993 | EP0557448A1 Preparation of nucleic acid samples |
| 09/01/1993 | EP0557442A1 Antithrombosis agents |
| 09/01/1993 | EP0557427A1 Human rotaviruses, vaccines and methods |
| 09/01/1993 | EP0557420A1 Method for inducing maturation of myeloid cells with interleukin-5 |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557388A1 Diagnosis and treatment of multiple sclerosis |
| 09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 09/01/1993 | EP0557352A1 Herbicide resistant plants |
| 09/01/1993 | EP0557300A1 Bispecific antibodies, method of production, and uses thereof |
| 09/01/1993 | EP0557273A1 Rat thyrotropin receptor gene and uses thereof |
| 09/01/1993 | EP0542929A4 Glycogen biosynthetic enzymes in plants |
| 09/01/1993 | EP0241539B1 Expression systems for overproduction of desired proteins |
| 09/01/1993 | EP0221108B1 Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences |
| 09/01/1993 | CN1021973C Production of proteins in procaryotes |
| 08/31/1993 | US5241050 Treating pancreatic diseases; antitumor agents |
| 08/31/1993 | US5241049 Neutrophil chemoattractants |
| 08/31/1993 | US5240913 Inhibitors of thrombin |
| 08/31/1993 | US5240911 Method of reducing blood sugar levels using a hypoglycemic agent |
| 08/31/1993 | US5240858 Recombinant vector having a Streptomyces achromogenes DNA sequence useful for gene amplification |
| 08/31/1993 | US5240855 Particle gun |
| 08/31/1993 | US5240849 Dna coding for enzyme capable of acylating the 4"-position of macrolide antibiotic |
| 08/31/1993 | US5240848 Cloning; genetic engineering |
| 08/31/1993 | US5240847 Cloned gene |
| 08/31/1993 | US5240846 Gene therapy vector for cystic fibrosis |
| 08/31/1993 | US5240845 Having specified amino acid sequence |
| 08/31/1993 | US5240842 Penetration of living cells by particles |
| 08/31/1993 | US5240841 E. coli resistance to Qβ virus infection |
| 08/31/1993 | US5240840 Dna superfragment cloning |
| 08/31/1993 | US5240839 Particle-mediated transformation of perennial fruit plants capable of adventitious budding on micropropagated tissue |
| 08/31/1993 | US5240838 Genetic engineering |
| 08/31/1993 | US5240837 CDNAS encoding somatotropin, expression vectors and hosts |